Tag archive for ‘COVID-19’
Sound Pharmaceuticals gets NIH grant for testing Covid-19 candidate SPI-1005 in phase 2 trials.
By businessnewstoday On Tuesday, April 6th, 2021
0 Comments

Sound Pharmaceuticals gets NIH grant for Covid-19 candidate SPI-1005

(adsbygoogle = window.adsbygoogle || []).push({}); Sound Pharmaceuticals has secured a grant of $3.1 million for supporting the evaluation of its COVID-19 treatment candidate SPI-1005 in two phase More...

Grifols phase 3 Covid-19 trial of hyperimmune globulins fails to meet objective
By businessnewstoday On Saturday, April 3rd, 2021
0 Comments

Grifols phase 3 Covid-19 trial of hyperimmune globulins fails to meet objective

Spanish pharma company Grifols said that the phase 3 ITAC clinical trial assessing hyperimmune globulins as a treatment for patients hospitalized with Covid-19 has failed to meet its primary endpoints. ITAC expands More...

Tiziana Life Sciences to launch phase 2 trial of Foralumab in Covid-19
By businessnewstoday On Tuesday, March 30th, 2021
0 Comments

Tiziana Life Sciences to launch phase 2 trial of Foralumab in Covid-19

Tiziana Life Sciences said that it plans to launch a phase 2 clinical trial to evaluate the nasal administration of Foralumab in moderate to severe Covid-19 patients. Foralumab is an anti-CD3 human monoclonal antibody More...

Foresee Pharmaceuticals begins FP-025 phase 2/3 trial in Covid-19 associated ARDS
By businessnewstoday On Sunday, March 28th, 2021
0 Comments

Foresee Pharmaceuticals begins FP-025 phase 2/3 trial in Covid-19 associated ARDS

Foresee Pharmaceuticals has started patient dosing in a phase 2/3 trial of FP-025 in adults having severe to critical Covid-19 with associated acute respiratory distress syndrome (ARDS). According to the Taiwanese More...

Janssen Covid‑19 vaccine gets conditional marketing authorization in EU
By Soujanya Ravi On Saturday, March 27th, 2021
0 Comments

Janssen Covid‑19 vaccine gets conditional marketing authorization in EU

The European Commission has granted a conditional marketing authorization (CMA) for the single dose Janssen Covid‑19 vaccine developed by the Janssen Pharmaceutical Companies of Johnson & Johnson. The Janssen More...

FDA accepts Airway Therapeutics’ IND for bronchopulmonary dysplasia treatment candidate AT-100 in preterm infants
By businessnewstoday On Saturday, March 27th, 2021
0 Comments

FDA accepts Airway’s IND for AT-100 for bronchopulmonary dysplasia treatment in preterm infants

Bronchopulmonary dysplasia treatment : Airway Therapeutics said that the US Food and Drug Administration (FDA) has accepted its investigational new drug (IND) application for developing AT-100 (rhSP-D) as a preventive More...

Pfizer begins phase 1 study of Covid drug candidate PF-07321332
By businessnewstoday On Wednesday, March 24th, 2021
0 Comments

Pfizer begins phase 1 study of Covid drug candidate PF-07321332

Pfizer said that it has initiated a phase 1 study in the US for assessing the oral antiviral therapeutic PF-07321332 against SARS-CoV-2, the virus that causes Covid-19. The US pharma giant said that it has completed More...

Model Medicines, Sanford Burnham Prebys forge AI-driven drug discovery partnership
By businessnewstoday On Tuesday, March 23rd, 2021
0 Comments

Model Medicines, Sanford Burnham Prebys forge AI-driven drug discovery partnership

AI drug discovery software company Model Medicines has signed a multi-target collaboration agreement with California-based Sanford Burnham Prebys Medical Discovery Institute for identifying and developing drugs More...

Moderna to supply 7m more doses of Covid-19 Vaccine Moderna to Philippines
By businessnewstoday On Monday, March 22nd, 2021
0 Comments

Moderna to supply 7m more doses of Covid-19 Vaccine Moderna to Philippines

Moderna has agreed to supply the Philippines with seven million additional doses of Covid-19 Vaccine Moderna, to take the confirmed order commitment to the Asian country to up to 20 million doses. The US biotech More...

AstraZeneca, US strike deal for up to 500k additional doses of Covid-19 antibody candidate AZD7442
By businessnewstoday On Tuesday, March 16th, 2021
0 Comments

Covid antibody candidate AZD7442 : AstraZeneca, US strike deal for additional doses

AstraZeneca has agreed to supply the US government with up to half a million additional doses of AZD7442, the company’s Covid-19 antibody candidate, for a sum of $205 million. In this connection, AstraZeneca has More...